Company History
Founded and established in 2016, KeYe Life
originally developed from a small research team in Southern University of
Science and Technology (SUSTech) in Shenzhen. Through the joint program between
University of Macau and SUSTech, high throughput screening was performed on a
small molecule library in order to find potential hits, which could inhibit RNA
helicase activity. The company further established its own experimental base in
Longhua District, Shenzhen in February, 2020. Starting from May, 2020, chemical
synthesis of small molecules were systematically carried out in the new
experimental base. Hundreds of derivative compounds were synthesized for drug
optimization. The small molecules were further developed for preclinical studies.
In September 2022, the company relocated to Pingshan District, Shenzhen and
expanded its experimental base.